Literature DB >> 6643784

Lymphatic albumin clearance from psoriatic skin.

B Staberg, P Klemp, M Aasted, A M Worm, P Lund.   

Abstract

In nine patients with untreated psoriasis vulgaris, human serum albumin labelled with 125I or 131I was injected intradermally in symmetrically located involved and uninvolved skin. The activity of the depots was followed by external detection, and the arrival of labelled albumin in plasma was monitored. In involved psoriatic skin the local mean half-time (T1/2) for tracer disappearance was 20.8 +/- 8.2 (S.D.) hr and in clinically normal skin, 29.1 +/- 9.6 (S.D.) hr. The difference was significant (p less than 0.002). Accordingly, the tracer from involved skin reached higher plasma levels than the tracer from uninvolved skin. However, under slight lymphatic stasis the appearance rate of radiolabelled albumin in plasma from both tissues was minimal during 1 to 2 hours after the injection, indicating that a local direct transvascular drainage of plasma albumin from the interstitium of diseased and normal skin was negligible. We conclude that the previously demonstrated increased extravasation of plasma proteins in involved psoriatic skin is compensated by an increased lymphatic drainage of plasma proteins, and not by an increased local transvascular return.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643784     DOI: 10.1016/s0190-9622(83)70198-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Follicular dendritic cells: dynamic antigen libraries.

Authors:  Balthasar A Heesters; Riley C Myers; Michael C Carroll
Journal:  Nat Rev Immunol       Date:  2014-06-20       Impact factor: 53.106

Review 2.  Stromal and hematopoietic cells in secondary lymphoid organs: partners in immunity.

Authors:  Deepali Malhotra; Anne L Fletcher; Shannon J Turley
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

3.  Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles.

Authors:  Simone Perazzolo; Danny D Shen; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2021-10-19       Impact factor: 3.784

4.  Cytokines are systemic effectors of lymphatic function in acute inflammation.

Authors:  Melissa B Aldrich; Eva M Sevick-Muraca
Journal:  Cytokine       Date:  2013-06-10       Impact factor: 3.861

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.